4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-045215
Chief Commercial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wettig Thane Chief Commercial Officer | 2023-08-07 | Grant or award | +200,000 | 308,261 | D | ||
| Derivatives | |||||||
| Wettig Thane Chief Commercial Officer | 2023-08-07 | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | D | ||
Loading xslF345X05/doc4.xml…